Tumor Biology · 2017 · 25 citations · 22 references
MedicineOncologyUrologyAutophagyMolecular OncologyUrologic OncologyAutophagy In CancerBiomarkers In Genitourinary CancerBiomarkers In Urologic OncologyBladder CancerCancer BiomarkersCancer TranscriptomicsCancer BioinformaticsCancer-associated AutophagyCoiled-coil DomainsCoiled-coil MotifsIndependent Cohort ValidationMicrotubule-associated Protein 1Polymerase Chain Reaction Assay ValidationQuantitative Polymerase Chain Reaction Validation
We sought to identify and validate a novel urinary autophagy transcript signature in patients with bladder cancer and evaluate its clinical utility. We performed an initial screening for seven autophagy transcript-based panel (autophagy-related protein 12 (ATG12); WD repeat domain, phosphoinositide interacting 2 (WIPI2); FYVE and coiled-coil domain-containing protein 1 (FYCO1); microtubule-associated protein light chain (MAPLC3); RB1-inducible coiled-coil 1 (RB1CC1); tachylectin-II-like beta-propeller domain 1 (TECPR1); and Unc-51-like kinase (ULK1)) that was identified based on bioinformatics analysis followed by SYBR Green-based polymerase chain reaction array validation in paired tissue and urine samples. Afterward, we evaluated the expression of differentially expressed autophagy transcripts in an independent validation set with reverse transcription quantitative real-time polymerase chain reaction in urine sediments of 140 patients with bladder cancer, 68 patients with benign urological lesions, and 74 healthy controls (age and sex matched). The expression levels of ATG12, FYCO1, TECPR1, and ULK1 in paired bladder tissue and urine samples were significantly lower in bladder cancer than in control group (p < 0.001). In the validation set, the receiver-operating characteristic curve analyses demonstrated that each urinary autophagy transcripts showed high sensitivity and specificity for distinguishing bladder cancer from non-bladder cancer patients (ATG12, 75.4% and 86.1%; FYCO1, 87% and 75.7%; ULK1, 85.5% and 75.6%; and TECPR1, 90% and 81.9%). We document and validate a novel autophagy transcript signature for human bladder cancer diagnosis: bilharzial and non-bilharzial types.
22
Rebecca L. Siegel, Kimberly D. Miller, Ahmedin Jemal · CA A Cancer Journal for Clinicians · 2015 · 11.9K citations · Full text
Autophagy in the Pathogenesis of Disease
Beth Levine, Guido Kroemer · Cell · 2008 · 7K citations · Full text
Economic Burden of Bladder Cancer Across the European Union
José Leal, Ramón Luengo-Fernández, Richard Sullivan et al. · European Urology · 2015 · 333 citations · Full text